Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06850363 · ClinicalTrials.gov registry record · NA
ExaStim Upper Limb Home Use Clinical Validation Study
A NA study, sponsored by Niche Biomedical, Inc. dba ANEUVO.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT06850363 is a NA study that has completed, run by Niche Biomedical, Inc. dba ANEUVO. The registered enrollment target is 33 participants.
The verdict
NCT06850363, a NA study, has completed, sponsored by Niche Biomedical, Inc. dba ANEUVO.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study consists of a baseline evaluation and 1-week training period (Week 0), a 4-week stimulation period (Weeks 1-4), and a follow-up visit (Week 5), for a total expected duration of participation for each subject of six weeks.
Interventions
- DEVICE ExaStim Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2025-03-17 |
| Est. Completion | 2026-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06850363
The ClinicalTrials.gov registry entry for NCT06850363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Niche Biomedical, Inc. dba ANEUVO, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExaStim Stimulation System is the first listed.
NCT06850363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06850363 about?
NCT06850363 is a clinical study titled "ExaStim Upper Limb Home Use Clinical Validation Study". This is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study consists of a baseli...
What is the current status of trial NCT06850363?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2025-03-17. Estimated completion is 2026-03-11.
What interventions are being tested in trial NCT06850363?
The interventions under investigation include: ExaStim Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT06850363?
This trial is sponsored by Niche Biomedical, Inc. dba ANEUVO, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.